Differences in Sociodemographic and Alcohol-Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study for Alcohol Use Disorder

Alcohol Clin Exp Res. 2020 Oct;44(10):2097-2108. doi: 10.1111/acer.14428. Epub 2020 Sep 30.

Abstract

Background: One of the challenges in early-stage clinical research aimed at developing novel treatments for alcohol use disorder (AUD) is that the enrolled participants are heavy drinkers, but do not seek treatment for AUD.

Aims: To compare nontreatment seekers with alcohol dependence (AD) from 4 human laboratory studies conducted at Brown University (N = 240; 65.4% male) to treatment seekers with AD from the multisite COMBINE study (N = 1,383; 69.1% male) across sociodemographic and alcohol-related clinical variables and to evaluate whether the variables that significantly differentiate the 2 samples predict the 3 main COMBINE clinical outcomes: time to relapse, percent days abstinent (PDA), and good clinical outcome.

Methods: Sample characteristics were assessed by parametric and nonparametric testing. Three regression models measured the association between the differing variables and the 3 main COMBINE clinical outcomes.

Results: The nontreatment seekers, compared to the treatment seekers, were more ethnically diverse, less educated, single, and working part-time or unemployed (p's < 0.05); they met fewer DSM-IV AD criteria and had significantly lower scores on alcohol-related scales (p's < 0.05); they were less likely to have a father with alcohol problems (p < 0.0001) and had a significantly earlier age of onset and longer duration of AD (p's < 0.05); they also had significantly more total drinks, drinks per drinking day, heavy drinking days (HDD), and lower PDA in the 30 days prior to baseline (p's < 0.0001 to <0.05). Having more HDD in the 30 days prior to baseline predicted all of the 3 COMBINE clinical outcomes. All the other characteristics mentioned above that differed significantly between the 2 groups predicted at least 1 of the 3 COMBINE clinical outcomes, except for level of education, age of onset, and duration of AD.

Conclusions: The observed differences between groups should be considered in efforts across participant recruitment at different stages of the development of new treatments for AUD.

Keywords: Alcohol Dependence; Alcohol Use Disorder; COMBINE; Medication Development; Nontreatment Seekers; Randomized Controlled Trial; Treatment Seekers.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acamprosate / administration & dosage
  • Acamprosate / therapeutic use
  • Adult
  • Age of Onset
  • Alcohol Deterrents / administration & dosage
  • Alcohol Deterrents / therapeutic use
  • Alcoholism / drug therapy
  • Alcoholism / psychology*
  • Alcoholism / therapy
  • Case-Control Studies
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Naltrexone / administration & dosage
  • Naltrexone / therapeutic use
  • Patient Acceptance of Health Care / psychology*
  • Patient Acceptance of Health Care / statistics & numerical data
  • Socioeconomic Factors
  • Treatment Outcome

Substances

  • Alcohol Deterrents
  • Naltrexone
  • Acamprosate